濮阳东方医院治疗阳痿技术非常哇塞濮阳东方看妇科口碑好很放心,濮阳东方医院男科割包皮很正规,濮阳东方医院妇科收费标准,濮阳东方医院割包皮手术便宜不,濮阳东方医院割包皮价格偏低,濮阳东方好预约吗,濮阳东方医院看妇科专不专业

WASHINGTON, March 9 (Xinhua) -- U.S. space shuttle Discovery landed safely at the Kennedy Space Center in Florida on Wednesday, ending its nearly 27-year flying career as the world's most- traveled spaceship.According to NASA, Discovery touched down at 11:57 a.m. EST ( 1657 GMT) after a 13-day resupply mission to the International Space Station (ISS)."For the final time: wheels stop," Discovery's commander Steven Lindsey called out as the shuttle rolled to a full stop.Discovery lifted off on Feb. 24 from the Kennedy Center and arrived at the space station on Feb. 26.During the mission, the astronauts installed a spare closet module on the space station, completed some important repairs and delivered the first humanoid robot, though it will need more time to be assembled and made operational.The 330-pound R2 consists of a head and a torso with two arms and two hands. Once it is unpacked -- likely several months after its arrival at the station -- it will initially be operated inside the Destiny laboratory for operational testing, but over time both its territory and its applications could expand.Aboard the station, its primary job for now is teaching engineers how dexterous robots behave in space. However, the hope is that through upgrades and advancements, it could one day venture outside the station to help spacewalkers make repairs or additions to the station or perform scientific work.

BEIJING, Feb. 12 (Xinhua) -- The Chinese government has reiterated a strict ban on hepatitis B tests during pre-employment physical examinations as many companies reportedly violated rules to require hepatitis B tests for job applicants.In a statement released Saturday, the Ministry of Health said that no health institutions are allowed to provide hepatitis B checks as part of pre-employment physical tests regardless of whether the examinees provide consent or not.On Feb. 10, 2010, the Ministry of Health, the Ministry of Education and the Ministry of Human Resources and Social Security jointly issued a circular demanding the cancellation of the hepatitis B tests during the health checks for school enrollment and employment nationwide.However, according to a survey released this week, which was conducted by the non-profit Beijing Yirenping Center, some 61.1 percent of the 180 state-run companies surveyed included hepatitis B checks in their pre-employment physical examinations.More surprisingly, 63 companies said that they would never consider hepatitis B carriers for a job or were reluctant to hire such people.Yu Fangqiang, the principal of the Yirenping Center, said that such violations mainly resulted from light punishment for violations and some health institutions' desire for profits.According to the survey, employers would only be fined between thousands to tens of thousands of yuan if they lose their lawsuits for bias against hepatitis B carriers.Meanwhile, a worker will spend a lot of time, energy and money to file a lawsuit and collect evidence in order to win.Liu Xiaonan, an associate professor with the China University of Political Science and Law, called on the government to hammer out a particular law and set up a special committee to investigate discrimination cases in order to ensure the rights of workers.In the statement released Saturday, the health ministry also ordered a careful investigation of all cases of hepatitis B discrimination, and promised that violators would be exposed and punished in accordance with laws and regulations.Medical tests show that hepatitis B virus can only be transmitted from mother to child during childbirth or by contact with the blood or other body fluids of an infected person.

BEIJING, Jan. 26 (Xinhua) -- The Chinese government Wednesday raised the minimum down payment requirement for the purchase of second home to 60 percent of the property's value from 50 percent, to curb property market speculation.The decision was announced in a statement released after an executive meeting of the State Council, China's cabinet, which was presided over by Premier Wen Jiabao.File photo taken on Nov. 14, 2010 shows a newly built residential community in east China's Shanghai Municipality.

LOS ANGELES, April 4 (Xinhua) -- A woman's breast milk cells may be used to predict cancer in future research, according to a study published by HealthDay News on Monday.In the study, researchers at the University of Massachusetts in Amherst collected breast milk from 271 women in the United States. All had either undergone a biopsy of the breast to check for cancer, or were scheduled for one.The researchers evaluated breast milk samples from the biopsied and non-biopsied breasts.The researchers first isolated potentially cancerous cells, known as epithelial cells, and then isolated DNA to look for signals that regulate tumor suppresser genes.In the next step, the researchers analyzed three genes among the many known to undergo a process called methylation in breast cancer. Methylation in a specific region of a gene can inhibit or suppress the expression of a gene.For one gene, SFRP1, the average methylation was higher in the biopsied breast, the study found.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast."It looks as if we can use the cells from breast milk to assess breast cancer risk," said Dr. Kathleen Arcaro, an associate professor of veterinary and animal sciences at the university.It's too soon, however, to assess the cancer detection rate associated with breast milk cell examination, she said."We can't say at this point for two reasons," she said. "One is, we need long-term follow-up. And the second really important reason is, we need to sample a larger panel of genes."Arcaro is to present her findings later Monday at the annual meeting of the American Association for Cancer Research in Orlando, Florida, according to HealthDay News.